Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea
· Delayed Price · Currency is KRW 5,680.00
+30.00 (0.53%)
At close: Mar 6, 2026
Sinsin Pharmaceutical Revenue
Sinsin Pharmaceutical had revenue of 30.11B KRW in the quarter ending September 30, 2025, with 11.71% growth. This brings the company's revenue in the last twelve months to 110.29B, up 4.31% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm)
110.29B
Revenue Growth
+4.31%
P/S Ratio
0.75
Revenue / Employee
309.79M
Employees
356
Market Cap
82.38B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hwail Pharmaceutical | 107.87B |
| GL Pharm Tech | 34.30B |
| Polaris AI Pharma | 63.94B |
| Ahn-Gook Pharmaceutical | 300.96B |
| BL Pharmtech | 6.98B |
| Daehan Nupharm | 201.59B |
| Sam-A Pharm. | 76.66B |
| H.PIO | 257.56B |